Burning Rock Biotech (BNR) Net Margin: 2020-2025
Historic Net Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to 13.97%.
- Burning Rock Biotech's Net Margin rose 1957.00% to 13.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.80%, marking a year-over-year increase of 6396.00%. This contributed to the annual value of 67.20% for FY2024, which is 5443.00% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Net Margin is 13.97%, which was down 107.51% from 6.73% recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Net Margin registered a high of 6.73% during Q2 2025, and its lowest value of 198.20% during Q2 2022.
- For the 3-year period, Burning Rock Biotech's Net Margin averaged around 71.79%, with its median value being 79.61% (2024).
- Per our database at Business Quant, Burning Rock Biotech's Net Margin surged by 12,464bps in 2021 and then crashed by 3,437bps in 2022.
- MRQ analysis of 5 years shows Burning Rock Biotech's Net Margin stood at 186.42% in 2021, then rose by 17bps to 154.26% in 2022, then increased by 14bps to 132.61% in 2023, then skyrocketed by 54bps to 61.63% in 2024, then surged by 77bps to 13.97% in 2025.
- Its Net Margin stands at 13.97% for Q3 2025, versus 6.73% for Q2 2025 and 10.21% for Q1 2025.